⌘K

Login Start Free

Home/Filings/4/0000950170-24-127310

4//SEC Filing

Akdamar Erol R 4

Accession 0000950170-24-127310

CIK 0000860730other

View on SEC.gov Company Profile

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 6:50 PM ET

Size

23.1 KB

Accession

0000950170-24-127310

Insider Transaction Report

Form 4

Period: 2024-11-12

HCA Healthcare, Inc.HCA

Group President

Transactions

Exercise/Conversion
Common Stock
2024-11-12$68.96/sh+20,000$1,379,200→ 20,000 total
Tax Payment
Common Stock
2024-11-12$350.53/sh−10,257$3,595,386→ 9,743 total
Sale
Common Stock
2024-11-14$353.00/sh−2,900$1,023,700→ 6,843 total
Exercise/Conversion
Stock Appreciation Right
2024-11-12−20,000→ 0 total
Exercise: $68.96Exp: 2025-02-04→ Common Stock (20,000 underlying)

Holdings

Common Stock
(indirect: By Trust)
60,497
Common Stock
(indirect: By LLC)
60,000

Footnotes (1)

[F1]The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.

Documents

2 files

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1

filerCIK 0001957739

Filing Metadata

Form type: 4
Filed: Nov 13, 7:00 PM ET
Accepted: Nov 14, 6:50 PM ET
Size: 23.1 KB

View on SEC.gov